Skip to content
Medical Health Aged Care

$100M could be saved annually if Australians living with osteoarthritis avoided knee replacements with a structured physiotherapy program

Monash University 2 mins read

An innovative Monash University-led study has shown that structured education and exercise therapy may be cost-effective measures that delay or avoid knee replacement surgery in people with lower pain levels, while improving healthcare sustainability. 

 

Knee replacement surgery can significantly reduce pain and improve quality of life for people with knee osteoarthritis. But with any good thing, there can be a tendency to overuse treatments beyond what is recommended. 

 

The research team, led by Dr Sean Docking from the School of Public Health and Preventive Medicine at Monash University, modelled the costs and health outcomes of a national physiotherapy program in comparison to knee replacements, based on Australian clinical registry data and published trial data.

 

The structured physiotherapy program that the researchers compared was GLA:D Australia, an education and exercise program that can be applied to everyday activities, ensuring participants develop skills to self-manage their osteoarthritis. GLA:D Australia is an implementation project led by co-author Associate Professor Christian Barton from La Trobe University.

 

“Unlike joint replacement surgery, physiotherapy-led programs are rarely subsidised by the government. Even if someone has private health insurance, there are still costs to access these programs, creating a significant barrier to their uptake,” Dr Docking said. “This barrier can push people to have surgery before trying other things.” 

 

Their findings, published in JAMA Network Open, suggest that the Australian healthcare system could save $100 million annually by delaying or avoiding knee replacement surgery in those with lower pain levels. 

 

“Our results suggest that structured education and exercise therapy is cost-effective for the first nine years and also over the lifetime in individuals with low pain levels. Our findings highlight the need for considered approaches that improve the sustainability of care and ensure that the right patient gets the right care at the right time,” Dr Docking said.  

 

The cost savings are only one way that programs like GLA:D may relieve mounting pressures on the Australian health system. Minimising joint replacements that are unwarranted can reduce surgery wait lists, with 30 per cent of public patients now waiting over a year for a knee replacement.

 

Co-author Professor Ian Harris, from the School of Clinical Medicine at the UNSW Sydney said one in four knee replacement surgeries in Australia may be unwarranted, and joint replacement surgeries take up more of the healthcare budget than any other procedure.

 

“Funding these physiotherapy-led programs would align with the government’s own best practice recommendations and improve the quality of care for knee pain. It could produce significant cost savings for our health system by avoiding unwarranted surgeries and enabling more timely access for those who really need surgery,” Professor Harris said. 

 

Read the full paper in JAMA Network Open: Lifetime Cost-Effectiveness of Structured Education and Exercise Therapy Knee Osteoarthritis in Australia.         

DOI: 10.1001/jamanetworkopen.2024.36715

 

- ENDS -

MEDIA ENQUIRIES 

Helena Powell

Media Communications Officer, Monash University 

M: +61 474 444 171

E: helena.powell@monash.edu 

 

GENERAL MEDIA ENQUIRIES

Monash Media

T: +61 (0) 3 9903 4840

E: media@monash.edu

For more Monash media stories, visit our news and events site 

Media

More from this category

  • Medical Health Aged Care
  • 02/10/2024
  • 00:01
Neuroscience Research Australia (NeuRA)

World Falls Guidelines updates poised to dramatically reduce falls and ease $2.3b healthcare burden

Key points Falls are Australia’s leading cause ofinjury, hospitalisation and death, costing our economy over $2.3 billion annually. Two simple modifications to the World…

  • Contains:
  • Medical Health Aged Care
  • 01/10/2024
  • 23:11
SEPHORA

SEPHORA and Rare Beauty by Selena Gomez Commit to Second Year of Make A Rare Impact Campaign in Honor of World Mental Health Day

SEPHORA renews commitment to donating 100%* of global Rare Beauty product sales to the Rare Impact Fund on October 10 PARIS–BUSINESS WIRE– Today, SEPHORA…

  • Contains:
  • Medical Health Aged Care
  • 01/10/2024
  • 22:10
EnGeneIC

Distinguished Oncologist, Professor Daniel Von Hoff joins the Scientific/Clinical Advisory Board of EnGeneIC Cancer Therapeutics

SYDNEY and NEW YORK, Oct. 01, 2024 (GLOBE NEWSWIRE) -- EnGeneIC, a clinical-stage biopharmaceutical company pioneering the development of a First-in-Class targeted nanocell for cancer therapy has today announced the appointment of Dr. Daniel Von Hoff to its Scientific/Clinical Advisory Board to advise EnGeneIC’s on its upcoming trial in metastatic pancreatic cancer.Professor Daniel Von Hoff, M.D. F.A.C.P. FASCO, FAACR is an internationally recognized physician and scientist. He is currently Distinguished Professor at the Translational Genomics Research Institute (TGEN) in Phoenix, Arizona, and City of Hope and holds the Virginia G Piper Distinguished Chair for Innovative Cancer Research at Honor Health…

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.